Heart Failure With Normal Ejection Fraction (HFNEF) in Hemodialysed Patients: Beneficial Effect of Ivabradine

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 150 participants.

Also called NCT01373619

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 150 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01373619
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Italy (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01373619. Non-randomized; no masking; primary purpose treatment. Start 2010-01 (registry gives no type); primary completion 2011-01 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Heart Failure With Normal Ejection Fraction (HFNEF) in Hemodialysed Patients: Beneficial Effect of Ivabradine
Condition
Heart Failure
Intervention (Drug)
Ivabradine
Lead sponsor
University of Campania Luigi Vanvitelli (class: other)

Record details

Record id
cardio:ct-nct01373619
Content hash
e01576a0132eec61a3f140f15040f0647185c88c17a6298707655ed79022322a